![Michael Clifford](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Clifford
Directeur/Membre du Conseil chez SynDevRx, Inc.
Postes actifs de Michael Clifford
Sociétés | Poste | Début | Fin |
---|---|---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Michael Clifford
Formation de Michael Clifford
Cornell University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sectorielle
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Commercial Services |
- Bourse
- Insiders
- Michael Clifford
- Expérience